title: Abdominal metastases from colorectal cancer: intraperitoneal therapy.
abstract: Patients with peritoneal metastasis from colorectal cancer represent a distinct subset with regional disease rather than systemic disease. They often have poorer survival outcomes with systemic chemotherapy. Optimal cytoreductive surgery and intraperitoneal chemotherapy (IPC) offers such patients a more directed therapy with improved survival. In this review, we discuss the diagnosis, evaluation and classification, as well as rational for treatment of peritoneal carcinomatosis (PC) secondary to colorectal cancer.
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Hamza
authors.initials: H
authors.lastname: Guend
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Sunil
authors.initials: S
authors.lastname: Patel
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Garrett M
authors.initials: GM
authors.lastname: Nash
keywords: Colorectal peritoneal carcinomatosis (PC); cytoreductive surgery; intraperitoneal chemotherapy (IPC)